Mark Voskoboynik
6PUBLICATIONS
37CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 17, 2026
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy from a First-in-Human Study of Volrustomig, a Novel PD-1/CTLA-4 Bispecific Antibody.Ben Tran, Mark Voskoboynik, Sang-We Kim
|Apr 08, 2020
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia.Jason D Lickliter, Hui K Gan, Mark Voskoboynik
|Dec 07, 2019
An update on adjuvant systemic therapies in melanoma.Evangeline Samuel, Maggie Moore, Mark Voskoboynik
|Dec 09, 2015
Clinicopathological characteristics associated with BRAF(K601E) and BRAF(L597) mutations in melanoma.Mark Voskoboynik, Victoria Mar, Sonia Mailer
|Sep 22, 2015
Immunotherapy for bladder cancer: rediscovering an old friend.Mark Voskoboynik, Sarah Rudman, Hendrik-Tobias Arkenau
|Apr 03, 2014
Combination therapies for the treatment of advanced melanoma: a review of current evidence.Mark Voskoboynik, Hendrik-Tobias Arkenau
Pageof 1
Frequent Collaborators
1 joint publications
Hendrik-Tobias Arkenau
1 joint publications
Evangeline Samuel
1 joint publications
Michael Lahn
1 joint publications
Howard Kallender
1 joint publications
Catello Somma
1 joint publications
Katherine Woods
1 joint publications
Andreas Behren
1 joint publications
Pablo Fernandez-Penas
1 joint publications
Michael Millward
1 joint publications
Ben Tran
